Navigation Links
Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Date:6/16/2008

lated to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated as a single agent in a Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients, in a Phase 1b clinical trial combining voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML, and as a single agent in a Phase 2 clinical trial in platinum-resistant ovarian cancer. In clinical trials conducted to date, voreloxin has been generally well tolerated and has shown objective responses in both solid and hematologic tumor types.

About Acute Myeloid Leukemia

AML is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the development of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
4. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
5. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
9. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
10. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... MINNETONKA, Minn. , Sept. 23, 2014   MedNet ... clinical study management systems, is pleased to announce that it ... for Clinical Data Management (SCDM) Annual Conference, to be held ... Las Vegas , Nevada. MedNet team members, in conjunction ... Partner Organizations who will also be in attendance, will ...
(Date:9/23/2014)... Fla. and DUBLIN ... (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology ... therapies for autoimmune diseases in emerging nations, today ... approved our common stock for DTC,s Deposit and ... Automated Securities Transfer Service ("FAST") transfer agent as ...
(Date:9/23/2014)... CHICAGO , Sept. 23, 2014  Hill-Rom (NYSE: ... agreement with Providence Health ( Renton, WA ... new agreement expands the companies, existing relationship as Hill-Rom ... Maternal, and Bariatric capital bed frame and surface products. ... largest health systems in the U.S.  It operates 34 ...
Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
... Stage Invention is Advancement toward Artificial Lungs, ... those suffering from lung ailments take note: Innovation ... from Battelle has earned a,patent for generating oxygen ... technology creates oxygen and controls carbon dioxide using ...
... Data ... Presentations -, SAN FRANCISCO, Sept. 24 ... development of,compounds for the treatment of cardiovascular disease, announced today that,it has ... study, including the sub-study of patients who received an,additional 3 months of ...
Cached Medicine Technology:Battelle Scientists Named on Patent for Making Oxygen From Light and Water 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. ... low birth weights, breast milk is more likely than a ... as cytomegalovirus (CMV), a new study finds. The researchers ... all of whom weighed 3.3 pounds or less and many ... infection, to see whether breast milk or transfusions carried the ...
(Date:9/23/2014)... -- Both drinking and getting drunk at an early ... high school students, a new study suggests. The ... who drink, could help expand alcohol-prevention efforts aimed at ... them from becoming binge drinkers, the researchers suggested. , ... use and progression to first heavy use as risk ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 What ... The National Quality Forum (NQF) released a ... http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( http://bit.ly/1tX3lzA ) ... cost of healthcare, how patients define affordability, and ... to get the best possible healthcare at the ...
(Date:9/23/2014)... 2014 (HealthDay News) -- Few children who ... behavioral therapy, and the rates vary six-fold across ... finds. Medication alone can manage symptoms for ... if they also receive behavioral therapy (psychotherapy), the ... data in more than 1,500 counties across the ...
(Date:9/23/2014)... grow up to earn up to 18 percent less ... Lundborg of Lund University, Paul Nystedt of Jnkping University ... all in Sweden. The team compared extensive information from ... the results are published in Springer,s journal Demography ... 145,193 Swedish-born brothers who enlisted in the Swedish National ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2
... awareness month, they would step up weekly workouts with ... facilities offered by the apartment community, CHICAGO, Feb. ... by eating right and working out on a weekly ... workout routine with convenient access to,workout facilities. During national ...
... country will become the "Gateway to,Healthy Living" for tens ... take better care of themselves., BOSTON, Feb. 28 ... program, participating health clubs will open their,doors -- free ... lives and,benefit from the supportive environment and professional knowledge ...
... Guidance for 2008, - Total Revenues Up 28% to $977.3mm for Full Year; Up 27% to ... Fourth Quarter, ... down 11% to $1.46); Up 27% to $0.47 for Fourth Quarter (GAAP EPS ... up 62% to $0.47), - Continuing New ...
... Puerto ... Rico, ... announced a multi-faceted marketing campaign designed to,promote ocular health and highlight the ... and Central,America., Following its launch of 1-DAY ACUVUE(R) MOIST(TM) in 2007,s ...
... Run Ads in Heavy Rotation Through Primary, ... of Ohio,s crucial,primary vote Tuesday, the National Nurses ... campaign across Ohio with,an emphatic message to the ... support real healthcare reform., The 60-second radio ...
... lupus, can affect nearly any part of the body, ... brain. Along with joint pain, muscle pain, unexplained ... events often accompany this autoimmune disease. Depending on ... patients experience signs and symptoms of neuropsychiatric (NP) disease. ...
Cached Medicine News:Health News:National Survey Reveals Most Renters Want What They Do Not Have: On-Site Workout Facilities 2Health News:Health Clubs Open Doors Free for 5th Annual Get Active America! Month and Become Gateway to Healthy Living 2Health News:Health Clubs Open Doors Free for 5th Annual Get Active America! Month and Become Gateway to Healthy Living 3Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 2Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 3Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 4Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 5Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 6Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 7Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 8Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 9Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 10Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 11Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 12Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 13Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 14Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 15Health News:Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers 2Health News:Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers 3Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 2Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 3Health News:Autoantibodies and neuropsychiatric events in lupus 2Health News:Autoantibodies and neuropsychiatric events in lupus 3
The Bledsoe Flatform Boot is designed with a flat innersole for procedures where toe dorsiflexion is not permissible....
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Bauerfeind™ AchilloTrain® The viscoelastic insert runs ... application of pressure and targeted intermittent ... reduction of painful irritation of the ... integrated viscoelastic heel wedge (raises heel ...
Medicine Products: